Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Nemvaleukin alfa

Catalog No. T77096Cas No. 2315268-27-8
Alias RDB-1450, RDB1450, Nemva, ALKS4230, ALKS 4230

Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.

Nemvaleukin alfa

Nemvaleukin alfa

Catalog No. T77096Alias RDB-1450, RDB1450, Nemva, ALKS4230, ALKS 4230Cas No. 2315268-27-8
Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.
Pack SizePriceAvailabilityQuantity
1 mg$413In Stock
5 mg$1,070In Stock
10 mg$1,720In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:6.0 mg/mL
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.
Targets&IC50
STAT5 phosphorylation:0.45 nM (EC50)
In vitro
Nemvaleukin alfa was able to activate lymphocyte subpopulations in cynomolgus monkeys and human samples with EC50 values ranging from 0.45 to 2.2 nM. Nemvaleukin alfa induced the activation of medium-affinity IL-2R on human cells (HH cells) after treatment for 30 minutes at concentrations ranging from 0-100 nM. Under the same conditions, Nemvaleukin alfa was also able to induce the expression of pSTAT5 in NK cells with an EC50 value of 0.45 nM. In addition, Nemvaleukin alfa was able to induce the activation of effector lymphocytes isolated from human peripheral blood when treated at a concentration of 0.5 nM for 5 days. [2][3]
In vivo
In a mouse model, Nemvaleukin alfa significantly inhibited small cell lung cancer (SCLC) tumor growth when administered subcutaneously at a dose of 6 mg/kg every 4 days.[1]
AliasRDB-1450, RDB1450, Nemva, ALKS4230, ALKS 4230
Chemical Properties
Cas No.2315268-27-8
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Nemvaleukin alfa | purchase Nemvaleukin alfa | Nemvaleukin alfa cost | order Nemvaleukin alfa | Nemvaleukin alfa in vivo | Nemvaleukin alfa in vitro